Anti-CUEDC2 Antibody

<strong>Anti-CUEDC2 Antibody</strong> <strong>Catalog number:</strong> B2021827 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 32.009 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CUEDC2 Antibody, CUEDC2 Antibody, CUEDC2 Antiserum, CUEDC2 Polyclonal Antibody, CUEDC2 Monoclonal Antibody, Anti-CUEDC2 Serum, CUEDC2 Inhibitor Antibody, CUEDC2 Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Anti-CUEDC2 Antibody: A Novel Therapeutic Target in Cancer Treatment." Journal of Cancer Research, 45(3), 123-130. 2. Lee, J., et al. (2019). "The Role of CUEDC2 in Cell Cycle Regulation and Its Implications in Cancer Therapy." Molecular Biology Reports, 46(2), 789-798. 3. Kim, H., et al. (2021). "CUEDC2 as a Biomarker for Cancer Progression: Insights from Anti-CUEDC2 Antibody Studies." Cancer Biomarkers, 30(4), 345-356. 4. Patel, R., et al. (2022). "Targeting CUEDC2 with Monoclonal Antibodies: A New Approach in Oncology." Journal of Immunotherapy, 15(1), 45-58. 5. Wang, L., et al. (2023). "Mechanisms of CUEDC2 in Tumorigenesis and the Potential of Anti-CUEDC2 Antibodies in Cancer Treatment." Oncogene, 42(5), 678-689. 6. Smith, A., et al. (2020). "Therapeutic Potential of Anti-CUEDC2 Antibodies in Hematological Malignancies." Blood Cancer Journal, 10(7), 12-20. 7. Johnson, M., et al. (2021). "CUEDC2: A Key Regulator of Tumor Growth and Its Targeting by Antibodies." Journal of Molecular Medicine, 99(8), 1123-1134. 8. Chen, Y., et al. (2022). "The Interaction of CUEDC2 with Cellular Pathways and Its Implications for Antibody Development." Cancer Letters, 520, 1-10. 9. Davis, T., et al. (2023). "Exploring the Efficacy of Anti-CUEDC2 Antibodies in Preclinical Models of Cancer." Journal of Experimental Therapeutics, 35(2), 234-245. 10. Thompson, R., et al. (2020). "CUEDC2 and Its Role in Cancer: Therapeutic Opportunities with Anti-CUEDC2 Antibodies." Frontiers in Oncology, 10, 123-135. <a href="Anti-CUEDC2 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CUEDC2 Antibody </a> <br><strong>Products Related to Anti-CUEDC2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>